Human HLA-C*06:02 cDNA from human EBV-transformed B cell line cDNA
|
Other clones in our bank
External Database Human HLA-Cw*0602 Reference sequence |
Sequence | RDB03377z.seq |
---|---|
Remarks, protocol and/or map (gif) | RDB03377.gif |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested. (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).) |
---|---|
Ordering | Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] |
提供条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).)。 |
---|---|
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB03377 | Human HLA-C*06:02 cDNA | DNA solution |
Materials & Methods section:
The Human HLA-C*06:02 cDNA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB03377). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Featured content
Featured content | HLA Clones (en) (English text) |
---|---|
Featured content | HLA Clones (ja) (Japanese text) |
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB18740_B1C9p1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV_Forward (Pr0016) Region: CMV pro,insert 5' Sequence file: RDB18740_B1C9a.seq |
---|
>03377_18740_B1C9_2_CMV-Forward_F03_18_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNG GGCGGTAGGC GTGTACGGTG GGAGGTCTAT 61 ATAAGCAGAG CTCTCTGGCT AACTAGAGAA CCCACTGCTT ACTGGCTTAT CGAAATTAAT 121 ACGACTCACT ATAGGGAGAC CCAAGCTGGC TAGCGTTTAA ACTTAAGCTT TTCTCCCCAG 181 ACGCCGAGAT GCGGGTCATG GCGCCCCGAA CCCTCATCCT GCTGCTCTCG GGAGCCCTGG 241 CCCTGACCGA GACCTGGGCC TGCTCCCACT CCATGAGGTA TTTCGACACC GCCGTGTCCC 301 GGCCCGGCCG CGGAGAGCCC CGCTTCATCT CAGTGGGCTA CGTGGACGAC ACGCAGTTCG 361 TGCGGTTCGA CAGCGACGCC GCGAGTCCGA GAGGGGAGCC CCGGGCGCCG TGGGTGGAGC 421 AGGAGGGGCC GGAGTATTGG GACCGGGAGA CACAGAAGTA CAAGCGCCAG GCACAGGCTG 481 ACCGAGTGAA CCTGCGGAAA CTGCGCGGCT ACTACAACCA GAGCGAGGAC GGGTCTCACA 541 CCCTCCAGTG GANGTATGGC TGCGACCTNN NCCCGACGGG CGCCTCCTCC GCGGGTATGA 601 CCAGTCCGCC TACGACGGCN AGGNNTACAT CGCCCTGAAC GANGANCTGC GCTCCNGGAN 661 NGNCGCGGAN NNNGCGNCTN NNATNNCCNN NCGNNNGNGG NNNNNNCNNN GNNNNNNNNN 721 N // |
Primer: bGH_rev3 (Pr0885) Region: bGHpA,insert 3' Sequence file: RDB18740_B1C9b.seq |
>03377_18740_B1C9_2_bGH_rev3_G03_21_ABI24.ab1 1 NNNNNNNNNN NNNNNGGNNG NNGNNNNNNN ACAGATGGCT GGCAACTAGA AGGCACAGTC 61 GAGGCTGATC AGCGGGTTTA AACGGGCCCT CTAGACTCGA GCGGCCGCGT CTCAGGCTTT 121 ACAAGCGATG AGAGACTCAT CAGAGCCCTG GGCACTGTTG CTGGACGCAG CCTGAGAGCA 181 GCTCCCTCCT TTTCCACCTG AGCTCTTCCT CCTACACATC ACAACAGCCA TCACAGCTCC 241 TAGGACAGCT AGGACAGCCA GGACAGCCAG GCCAGCAACG ATGCCCACGA TGGGGATGGT 301 GGGCTGGGAA GATGGCTCCC ATCTCAGGGT GAGGGGCTCT GGCAGCCCCT CGTGCTGCAC 361 ATGGCACGTG TATCTCTGCT CTTCTCCAGA AGGCACCACC ACAGCTGCCC ACTTCTGGAA 421 GGTTCCATCT CCTGCTGGCC TGGTCTCCAC AAGCTCGGTG TCCTGAGTTT GGTCCTCGCC 481 ATCCCGCTGC CAGGTCAGTG TGATCTCCGC AGGGTAGAAG CCCAGGGCCC AGCACCTCAG 541 GGTGGCCTCA TGGTCAGAGA CGGGATGGTG GGTCACGTGT GTCTTTGGGT GTTCCGCGCG 601 CTGCANCGTC TCCTTCCCGT TCTCCNGGTA TCTGCGGANC CACTCCACGC ACGTGCCCTN 661 CANGTNNNNT CTNCNCNGCT NCNNNNCNNG GNNNGNNTNC NNCTNGCGCT GGGNGNNNNN 721 NNNNN // |
Primer: SV40pro_ori_F (Pr0731) Region: SV40 pro_ori, NeoR Sequence file: RDB18740_B1C9c.seq |
>03377_18740_B1C9_2_SV40pro_ori_F_H03_24_ABI24.ab1 1 NNNNNNNNNN NNNNGCCGCC TCTGCCTCTG ANCTATTCCN GAAGTAGTGA GGAGGCTTTT 61 TTGGAGGCCT ANGCTTTTGC AAAAAGCTCC CGGGAGCTTG TATATCCATT TTCGGATCTG 121 ATCAAGAGAC AGGATGAGGA TCGTTTCGCA TGATTGAACA AGATGGATTG CACGCAGGTT 181 CTCCGGCCGC TTGGGTGGAG AGGCTATTCG GCTATGACTG GGCACAACAG ACAATCGGCT 241 GCTCTGATGC CGCCGTGTTC CGGCTGTCAG CGCAGGGGCG CCCGGTTCTT TTTGTCAAGA 301 CCGACCTGTC CGGTGCCCTG AATGAACTGC AGGACGAGGC AGCGCGGCTA TCGTGGCTGG 361 CCACGACGGG CGTTCCTTGC GCAGCTGTGC TCGACGTTGT CACTGAAGCG GGAAGGGACT 421 GGCTGCTATT GGGCGAAGTG CCGGGGCAGG ATCTCCTGTC ATCTCACCTT GCTCCTGCCG 481 AGAAAGTATC CATCATGGCT GATGCAATGC GGCGGCTGCA TACGCTTGAT CCGGCTACCT 541 GCCCATTCGA CCACCAAGCG AAACATCGCA TCGAGCGAGC ACGTACTCGG ATGGAAGCCG 601 GTCTTGTCGA TCANGANGAN CTGGANGAAN ANCATCNNGG GCTCGCGCCN GCCGAANNNN 661 NNGCCNGGNT CNNNGNNCNN ATGNCCNANN NNANNNNCTC NTCNNGACCN NNNNNNANGN 721 NNGNNNGNNN ANNNNNNNGN NNNNAANNNN NNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Akatsuka, Y., Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens, 59, 502-511 (2002). PMID 12445320. |
---|
2023.05.01
GNP_filter3_RDBDEP_html_230501.pl